John A. Wendt - Concepedia

Author

John A. Wendt

Pfizer (United States)

Also Known As

J. A. WENDT, John A Wendt, John A. Wendt

Publications

374

Citations

H-Index

Concepts

All Affiliations

Pfizer (United States)University of Kansas

About

John A. Wendt is an author at Pfizer (United States) specializing in medicine, pharmacology, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	138
2	Biochemistry	5	5	176
3	Engineering	3	3	142
4	Biomolecular Engineering	3	3	85
5	Natural Sciences	1	1	67

John A. Wendt

Publications

346

Citations

H-Index

Page 1

	Year	Citations
First Asymmetric Total Synthesis of (+)-Sparteine Brenton T. Smith, John A. Wendt, Jeffrey Aubé Organic Letters	2002	113
Synthesis of (.+-.)-Fredericamycin A John A. Wendt, Paul J. Gauvreau, Robert D. Bach Journal of the American Chemical Society Bioorganic ChemistryEngineeringAltmetric Attention ScoreBibliometricsOrganic Chemistry	1994	67
Convergent, parallel synthesis of a series of β-substituted 1,2,4-oxadiazole butanoic acids as potent and selective αvβ3 receptor antagonists Mark L. Boys, Lori A. Schretzman, Nizal S. Chandrakumar, Bioorganic & Medicinal Chemistry Letters EngineeringMedicineDrug DiscoveryDiversity-oriented SynthesisPharmacological Agent	2005	47
Synthesis and SAR comparison of regioisomeric aryl naphthyridines as potent mGlu5 receptor antagonists Paul Galatsis, Koji Yamagata, John A. Wendt, Bioorganic & Medicinal Chemistry Letters Regioisomeric Aryl NaphthyridinesMolecular PharmacologyBiochemistryFunctional SelectivityMedicine	2007	29
Synthesis and SAR of 2-aryl pyrido[2,3-d]pyrimidines as potent mGlu5 receptor antagonists John A. Wendt, Susan Deeter, Susan E. Bove, Bioorganic & Medicinal Chemistry Letters BiochemistryFunctional SelectivityMedicineMechanism Of ActionPharmacological Agent	2007	29
Toward the synthesis of sparteine: Intramolecular Schmidt reactions on a norbornanone platform John A. Wendt, Jeffrey Aubé Tetrahedron Letters Combinatorial ChemistryNovel OrganocatalystsEngineeringNorbornanone PlatformBiochemistry	1996	28
Rational design of 7-arylquinolines as non-competitive metabotropic glutamate receptor subtype 5 antagonists Jared B. J. Milbank, Christopher S. Knauer, Corinne E. Augelli‐Szafran, Bioorganic & Medicinal Chemistry Letters BiochemistryFunctional SelectivityRational DesignMedicineRational Drug Design	2007	23
Synthesis of 2,5-thiazole butanoic acids as potent and selective αvβ3 integrin receptor antagonists with improved oral pharmacokinetic properties John A. Wendt, Hongwei Wu, Heather G. Stenmark, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryPharmaceutical ScienceMedicinePharmacological AgentPharmacotherapy	2005	10

Page 1